After teasing at I/O 2024 and announcing this April, Google today is launching Workspace Studio as a new automation tool that lets you “design, manage, and share AI agents” powered by Gemini 3’s ...

Disney has been taking action to protect its intellectual property from the ravages of generative artificial intelligence—but it’s also taking steps to harness generative AI for its own benefit. In an ...

Disney+ subscribers could soon be getting “game-like features” in the not too distant future, and it has artificial intelligence (AI) to thank, according to Bob Iger. The media giant is also looking ...

Detroit's Gleyber Torres saw his numbers go down in the second half, but still could stay with the Tigers. Steph Chambers / Getty Images LAS VEGAS — One executive predicts all 13 free agents who ...

If you feel overwhelmed or stuck in a close relationship, therapist KC Davis, author of Who Deserves Your Love, has a list of questions to help you decide whether you should continue to engage. Davis ...

It would help a lot in a transition from oracle to IvorySQL if sqlplus would be supported in one or the other way. Even getting the 90% done would be a great help. I was parsing the context into a ...

Hundreds of people who were once detained at the troubled immigration jail in the Florida Everglades, dubbed “Alligator Alcatraz,” have disappeared. Democracy Now! speaks with Shirsho Dasgupta, a ...

Abstract: Generating accurate SQL from users’ natural language questions (text-to-SQL) remains a long-standing challenge due to the complexities involved in user question understanding, database ...

Is President Trump working to build his own personal army? Investigative reporter Radley Balko responds to Trump’s new executive order for a “standing National Guard quick reaction force” that the ...

Microsoft is betting big on this class of laptops with built-in AI processing. Here's what sets these systems apart right now. I've been testing PC and mobile software for more than 20 years, focusing ...

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.